Related Experiment Videos
[Biomedical ethics in molecular medicine]
1imatsuda@bronze.ocn.ne.jp
No to Hattatsu = Brain and Development
|June 16, 2006
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Prevalence of Fabry disease in dialysis patients: Japan Fabry disease screening study (J-FAST).
Clinical and experimental nephrology·2015
Curvature of cervical vertebra in 8020 achievers observed by lateral cephalogram.
The Bulletin of Tokyo Dental College·2008
Community engagement and informed consent in the International HapMap project.
Community genetics·2007
[Successful treatment with topiramate in a case of idiopathic intracranial hypertension refractory to acetazolamide].
No to hattatsu = Brain and development·2018
[Clinical characteristics of early juvenile GM2 gangliosidosis: a case report].
No to hattatsu = Brain and development·2018
[Non-invasive positive pressure ventilation during the management of severe spinal muscular atrophy type I].
No to hattatsu = Brain and development·2018
[Ictal arterial spin labeling MRI findings in two cases of acute confusional migraine].
No to hattatsu = Brain and development·2018
[A case of West syndrome with a deletion at chromosome 2q24.3-q31.3].
No to hattatsu = Brain and development·2018
[Irreversible cerebral ischemia caused by febrile status epilepticus in Sturge-Weber syndrome type III].
No to hattatsu = Brain and development·2018
Development of a Novel, Eco-Friendly Mechanical Cell Lysis Process Using Hollow Fiber Filter for AAV Manufacturing.
Biotechnology and bioengineering·2026
Programmed repair of disease-causing UGA premature termination codons in mammalian brain.
Nucleic acids research·2026
Molecular profiling and functional analyses of umbilical cord mesenchymal stem cell-derived extracellular vesicles for dry eye diseases.
Extracellular vesicles and circulating nucleic acids·2026
Immunotherapy for tuberculosis: current landscape, mechanistic insights, and translational perspectives.
Frontiers in immunology·2026
Real-World Effectiveness and Safety of Tildrakizumab in Patients With Moderate-to-Severe Psoriasis After Failure of Ustekinumab: A Multicenter Retrospective Study.
The Journal of clinical and aesthetic dermatology·2026